The general public subscription schedule for IPO stock MS Bio has fully concluded. With attention focused on the final number of subscription applications, equal allocation shares, and the proportional competition ratio, investors' eyes are expected to shift to the listing scheduled for the 22nd and the stock's movement on its first trading day.

MS Bio conducted its general subscription through KB Securities over two days, from the 12th to the 13th. The total number of subscription applications was tallied at 286,498, with 1.75 shares allocated in equal distribution and a proportional competition ratio of 3,076.02 to 1.

Attention on Whether It Can Achieve a ' quadrupling' Ahead of the Listing on the 22nd

MS Bio is scheduled to list on the stock market on the 22nd. Of interest is how the stock price will trend relative to the offering price after listing. In particular, attention is on whether it can achieve the so-called 'quadrupling' on its first trading day, which refers to the stock price rising to four times the offering price on the day of listing. If MS Bio records a quadrupling on its first trading day, the stock price could rise to as much as 31,200 won.

However, this figure merely assumes the upper limit of the price reachable on the listing day and does not mean the actual stock price will rise to that level.

Volatility Should Be Considered Alongside High Growth Expectations

In the IPO market, not only the subscription results but also the stock price trends formed in actual trading after listing are important. Therefore, rather than approaching the stock based solely on expectations of a high surge on the first trading day, it is necessary to also consider the possibility of volatility.

It remains to be seen what kind of performance MS Bio, having completed its subscription schedule, will show on its listing day on the 22nd.

[※ This article is intended to convey market trends and is not intended to recommend investment in any specific stock.]